Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6286576

O=C(Cc1ccsc1)N[C@@H](Cc1ccccn1)C(=O)Nc1ccc(C(c2ccc(NC(=O)[C@H](Cc3ccccn3)NC(=O)Cc3ccsc3)cc2)c2ccc(NC(=O)[C@H](Cc3ccccn3)NC(=O)Cc3ccsc3)cc2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 3/20 0.41
TSHR P16473 2/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MET P08581 4/20 0.39
GPR142 Q7Z601 1/20 0.38
CAPN1 P07384 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7035725 0.92 USP30 (0.43) USP30TSHRHDAC3HDAC4HDAC1
Trifluoroacetic Acid SCHEMBL6291084 0.87 USP30 (0.40) USP30HDAC3HDAC4HDAC1HDAC7
Trifluoroacetic Acid SCHEMBL6287803 0.86 RAB9A (0.36) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6287170 0.84 HDAC8 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
Trifluoroacetic Acid SCHEMBL6287901 0.79 KDM1A (0.47) HDAC3HDAC4HDAC1HDAC7HDAC2
Trifluoroacetic Acid SCHEMBL6356125 0.78 HDAC1 (0.43) USP30HDAC1MAPTCAPN1ALDH1A1
SCHEMBL6287981 0.77 RAB9A (0.47) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6291026 0.76 RAB9A (0.49) TSHRMAPTSMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL6288075 0.75 RAB9A (0.46) MAPTSMN1; SMN2L3MBTL1POLBNPC1
Trifluoroacetic Acid SCHEMBL6290396 0.75 HDAC1 (0.55) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK USP30 3943/4885TSHR 435/4885HDAC3 3546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.